Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti–PD-1 for patients with anti–PD-1–refractory tumors
Keywords:
Intratumoral therapies
BO-112
Polycytidylic acid
Programmed cell death protein–1 (PD-1)
Editorial note:
© 2020
The Authors, some
rights reserved;
exclusive licensee
American Association
for the Advancement
of Science. No claim
to original U.S.
Government Work
Citation:
Rodriguez-Ruiz, M.E. (María Esperanza); Marquez-Rodas, I. (Iván); Longo, F. (Federico); et al. "Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti–PD-1 for patients with anti–PD-1–refractory tumors". Science Translational Medicine. 12 (565), 2020, 1 - 11
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.